📣 Great opportunity for anyone involved in the drug development process. CatalystBio founders, Greta Wodarcyk and Michael Boyne…Read More

🎉 Congratulations to PolarityBio on their BLA submission! The CatalystBio team is proud to have supported PolarityBio on their BLA submission to the U.S. FDA for SkinTE® – a first-in-class autologous cutaneous multicellular therapy targeting diabetic foot ulcers (DFUs). If approved, this would be the…   ​ Read More

One of our clients is hiring in the Denver-area. This growing start-up working the cell therapy space is looking for: QC Research Scientist: The Quality Control (QC) Scientist supports cGMP manufacturing operations by performing and overseeing analytical testing for release, stability, and in-process control of cell-based…   ​ Read More

We are excited to announce that our Co-Founder and Principal, Greta Wodarcyk, PhD, will be a featured expert at the upcoming  ​ Read More

Michael Boyne, Co-Founder and Principal, will be sharing his deep expertise at the CASSS – Sharing Science Solutions Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry in Costa Mesa, CA. Michael will be sharing his…   ​ Read More

Thank you to everyone who attended this session and joined in on the lively discussion! Special thanks to our host Biocom California, moderator Franklin Rice at The Sights Group, and panelist Mark Kaufmann at Acurex Biosciences.   ​ Read More

At #BIO2025, Michael Boyne, Co-founder and Principal at CatalystBio, spoke on clinical trial development in the U.S. as part of a panel examining regional approaches to conducting trials and the diverse opportunities available across different countries. The audience also heard valuable insights from Jinhak Kim…   ​ Read More

🌐 It was an international effort as we kicked off a fantastic collaborative seminar at the Korean Pavilion at #BIO2025, highlighting the opportunities of running clinical trials in Australia, Korea and California. 🔺 Our Director Partnerships Jarrod Belcher GAICD opened the seminar explaining that each…   ​ Read More

We’re excited to share that CatalystBio will be attending the CASSS – Sharing Science Solutions Cell and Gene Therapy Products (CGTP) Symposium 2025! Greta Wodarcyk and Michael Boyne will be representing our team, joining important discussions on the latest challenges and advancements in cell and…   ​ Read More

Yesterday, Greta Wodarcyk and Michael Boyne had the exciting opportunity to speak with a group of trainees in Northwestern University’s Biotechnology Training Program about a critical milestone in drug development: the path to an Investigational New Drug (IND) application. Their seminar, “Path to IND — Moving from the…   ​ Read More